Citius Pharmaceuticals Inc CTXR
NASDAQ · United States · Health Technology
$0.5316-0.01 (-1.79%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-08-14 | -0.34 | -0.36 | +5.6% | $1.49M | -72.6% | -23.4%$0.73→$0.56 |
| Q2 2026 | 2026-05-15 | -0.95 | -0.32 | -196.9% | — | — | -26.8%$0.72→$0.53 |
| Q1 2026 | 2026-02-13 | -0.38 | -0.30 | -26.7% | — | — | -6.4%$0.79→$0.74 |
| Q4 2025 | 2025-12-23 | -0.11 | -0.24 | +54.2% | — | — | -23.7%$1.05→$0.80 |
| Q3 2025 | 2025-08-12 | -0.80 | -0.21 | -281.0% | — | — | — |
| Q2 2025 | 2025-05-14 | -1.27 | 0.11 | -1,254.5% | — | — | — |
| Q1 2025 | 2025-02-14 | -1.30 | -1.25 | -4.0% | — | — | — |
| Q4 2024 | 2024-12-27 | -5.80 | -1.50 | -286.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.